DariaBarrettCrittendenMD

PubMed

• 11 citations
  Safety, Pharmacokinetics, Pharmacodynamics, and Formulation of Liver-Distributed Farnesoid X-Receptor Agonist TERN-101 in Healthy Volunteers.
  Yujin Wang, Daria B. Crittenden, Clarence Eng, Qiong Zhang, Pengfei Guo, Diana Chung, Martijn Fenaux, Kevin Klucher, Christopher T. Jones, Feng Jin, Erin Quirk, Michae...> ;Clinical Pharmacology in Drug Development. 2021 Jul 24
• 2 citations
  Allopurinol use and type 2 diabetes incidence among patients with gout: A VA retrospective cohort study.
  Anastasia Slobodnick, Michael Toprover, Jeff Greenberg, Daria B. Crittenden, Virginia C. Pike, Yingzhi Qian, Hua Zhong, Michael H. Pillinger> ;Medicine. 2020 Aug 28
• 15 citations
  Predictors of imminent risk of fracture in Medicare-enrolled men and women
  Akeem Yusuf, Yan Hu, David Chandler, Daria B. Crittenden, Richard Barron> ;Archives of Osteoporosis. 2020 Aug 3
• 48 citations
  Determinants of imminent fracture risk in postmenopausal women with osteoporosis
  Rich Barron, Gerry Oster, Andreas Grauer, Daria B. Crittenden, Derek Weycker> ;Osteoporosis International. 2020 Jul 1
• 25 citations
  T-Score as an Indicator of Fracture Risk During Treatment With Romosozumab or Alendronate in the ARCH Trial
  Felicia Cosman, E. Michael Lewiecki, Peter R. Ebeling, Eric Hesse, Nicola Napoli, Toshio Matsumoto, Daria B. Crittenden, Maria Rojeski, Wenjing Yang, Cesar Libanati, S...> ;Journal of Bone and Mineral Research. 2020 Jul 1
• 16 citations
  Colchicine Use and Incident Coronary Artery Disease in Male Patients With Gout.
  Binita Shah, Michael Toprover, Daria B. Crittenden, Susanna Jeurling, V. Courtney Pike, Svetlana Krasnokutsky, Yuhe Xia, Mark Fisher, Anastasia Slobodnick, Craig Tenne...> ;The Canadian Journal of Cardiology. 2020 Nov 1
• 15 citations
  Favorable skeletal benefit/risk of long-term denosumab therapy: a virtual-twin analysis of fractures prevented relative to skeletal safety events observed
  Serge Ferrari, E. Michael Lewiecki, Peter W. Butler, David L. Kendler, Nicola Napoli, Shuang Huang, Daria B. Crittenden, Nicola Pannacciulli, Ethel S. Siris, Neil Binkley> ;Bone. 2020 Feb 21
• 30 citations
  Increased bone mineral density for 1 year of romosozumab, vs placebo, followed by 2 years of denosumab in the Japanese subgroup of the pivotal FRAME trial and extension
  Akimitsu Miyauchi, Rajani Dinavahi, Daria B. Crittenden, Wenjing Yang, Judy Maddox, Etsuro Hamaya, Yoichi Nakamura, Cesar Libanati, Andreas Grauer, Junichiro Shimauchi> ;Archives of Osteoporosis. 2019 Jun 5
• 2 citations
  Low-Dose Allopurinol Promotes Greater Serum Urate Lowering in Gout Patients with Chronic Kidney Disease Compared with Normal Kidney Function.
  Michael Toprover, Daria B. Crittenden, Dodji V. Modjinou, Cheongeun Oh, Svetlana Krasnokutsky, Mark Fisher, Robert T. Keenan, Michael H. Pillinger> ;Bulletin of the Hospital for Joint Disease. 2019 Mar 1
• 48 citations
  Romosozumab FRAME Study: A Post Hoc Analysis of the Role of Regional Background Fracture Risk on Nonvertebral Fracture Outcome
  Felicia Cosman, Daria B. Crittenden, Serge Ferrari, E. Michael Lewiecki, Juan Jaller-Raad, Cristiano A. F. Zerbini, Cassandra E Milmont, Paul D Meisner, Cesar Libanati...> ;Journal of Bone and Mineral Research. 2018 Aug 1
• 80 citations
  FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab.
  Felicia Cosman, Daria B. Crittenden, Serge Ferrari, Aliya Khan, Nancy E Lane, Kurt Lippuner, Toshio Matsumoto, Cassandra E Milmont, Cesar Libanati, Andreas Grauer> ;Journal of Bone and Mineral Research. 2018 Jul 1
• 31 citations
  Effect of denosumab on fasting glucose in women with diabetes or prediabetes from the FREEDOM trial.
  Nicola Napoli, Nicola Pannacciulli, Eric Vittinghoff, Daria B. Crittenden, Jang Yun, Andrea Wang, Rachel B. Wagman, Ann V. Schwartz> ;Diabetes/metabolism Research and Reviews. 2018 May 1
• 228 citations
  Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised...
  Bente L. Langdahl, Cesar Libanati, Daria B. Crittenden, Michael A. Bolognese, Jacques P. Brown, Nadia Daizadeh, Eva Dokoupilova, Klaus Engelke, Joel S. Finkelstein, Ha...> ;Lancet. 2017 Sep 30
• 55 citations
  Romosozumab increases bone mineral density in postmenopausal Japanese women with osteoporosis: A phase 2 study
  Hideaki Ishibashi, Daria B. Crittenden, Akimitsu Miyauchi, Cesar Libanati, Judy Maddox, Michelle Fan, Li Chen, Andreas Grauer> ;Bone. 2017 Oct 1
• 13 citations
  A Model for Assessing the Clinical and Economic Benefits of Bone-forming Agents for Reducing Fractures in Postmenopausal Women at High, Near-term Risk of Osteoporotic ...
  Claire E O'Hanlon, Anju Parthan, Morgan Kruse, Shannon Cartier, Björn Stollenwerk, Yawen Jiang, John P. Caloyeras, Daria B. Crittenden, Richard Barron> ;Clinical Therapeutics. 2017 Jul 1
• 25 citations
  Comparison of dual-energy CT, ultrasound and surface measurement for assessing tophus dissolution during rapid urate debulking
  Dodji V. Modjinou, Svetlana Krasnokutsky, Soterios Gyftopoulos, Virginia C. Pike, Elaine Karis, Robert T. Keenan, Kristen Lee, Daria B. Crittenden, Jonathan Samuels, M...> ;Clinical Rheumatology. 2017 Jun 16
• 29 citations
  Predictors of near-term fracture in osteoporotic women aged ≥65 years, based on data from the study of osteoporotic fractures
  Derek Weycker, John Edelsberg, Rich Barron, Mark Atwood, Gerry Oster, Daria B. Crittenden, Andreas Grauer> ;Osteoporosis International. 2017 Jun 7
• 58 citations
  Greater Gains in Spine and Hip Strength for Romosozumab Compared With Teriparatide in Postmenopausal Women With Low Bone Mass
  Tony M. Keaveny, Daria B. Crittenden, Michael A. Bolognese, Harry K. Genant, Klaus Engelke, Beatriz Oliveri, Jacques P. Brown, Bente L. Langdahl, Chris Yan, Andreas Gr...> ;Journal of Bone and Mineral Research. 2017 Sep 1
• 21 citations
  A Survey of Women's Awareness of and Reasons for Lack of Postfracture Osteoporotic Care.
  Denise M. Boudreau, Onchee Yu, Akhila Balasubramanian, Heidi S. Wirtz, Andreas Grauer, Daria B. Crittenden, Delia Scholes> ;Journal of the American Geriatrics Society. 2017 Aug 1
• 1 citations
  Unmasking romosozumab: response to commentsby Uzoigwe et al.
  Felicia Cosman, Daria B. Crittenden, Cesar Libanati> ;Osteoporosis International. 2017 Feb 17
• 834 citations
  Romosozumab Treatment in Postmenopausal Women with Osteoporosis.
  Felicia Cosman, Daria B. Crittenden, Jonathan D. Adachi, Neil Binkley, Edward Czerwiński, Serge Ferrari, Lorenz C. Hofbauer, E. Lau, E. M. Lewiecki, Akimitsu Miyauchi,...> ;The New England Journal of Medicine. 2016 Sep 18
• 72 citations
  Predicting imminent risk for fracture in patients aged 50 or older with osteoporosis using US claims data
  M. M. Bonafede, Nianwen Shi, Rich Barron, Xiaoyan Li, Daria B. Crittenden, David Chandler> ;Archives of Osteoporosis. 2016 Jul 30
• 5 citations
  Cardiovascular Disease Prevalence in Patients with Osteoarthritis, Gout, or Both.
  Bang D, Jinfeng Xu, Robert T. Keenan, Pike, RA Lehmann, Craig Tenner, Daria B. Crittenden, Michael H. Pillinger, Svetlana Krasnokutsky> ;Bulletin of the Hospital for Joint Disease. 2016 Jun 1
• 42 citations
  Hyperuricemia, gout, and related comorbidities: cause and effect on a two-way street.
  Elaine Karis, Daria B. Crittenden, Michael H. Pillinger> ;Southern Medical Journal. 2014 Apr 1
• 148 citations
  The Crystallization of Monosodium Urate
  Miguel A. Martillo, Lama Nazzal, Daria B. Crittenden> ;Current Rheumatology Reports. 2014 Feb 1
• Join now to see all